The electrophoretic separation of alkaline situation may be radically altered by the introphosphatase iso-enzymes (Newton, 1967) or duction of techniques for the measurement of measurement of the 5'-nucleotidase activity in blood parathormone levels by immuno-assay serum (Dixon and Purdom, 1954; Wooton, 1964) (Potts, Aurbach and Sherwood, 1966) and for can assist in resolving doubts as to the hepatic the localisation of parathyroid adenomata by or bony origin of a raised non-specific serum the selective uptake of 16-Se-methionine (Potchen, phosphatase. Wilson and Dealy, 1965) . Hypercalcemia due to primary hyperparathyroidism is distinguished from hypercalcemia due to sarcoidosis or vitamin D intoxication by its lack of response to cortisone (Dent, 1962) . The effect of cortisone on hypercalcemia associated with malignant disease is variable. In osteomalacia, secondary (compensatory) hyperparathyroidism can, at best, only raise the serum calcium to normal levels; hypercalcemia in this situation is usually iatrogenic (vitamin D intoxication) but may indicate the development of an autonomous adenoma ("tertiary hyperparathyroidism").
Tests for hypoparathyroidism based on the phosphaturic response to injected parathyroid extract (Ellsworth and Howard, 1934) have been widely regarded as unsatisfactory (Dent, 1953) . It seems, however, from the results of Evanson (1966) that the effects may be sufficiently characteristic to be of value in the differential diagnosis of hypocalcemia, In this country, osteomalacia is rarely due to a deficiency of vitamin D. It is commonly associated either with the malabsorption syndrome or with a renal lesion. Fecal fat estimations and jejunal biopsy are the key investigations in the diagnosis of malabsorption.
Difficulty in obtaining the complete and accurate six-day stool collections which are required for the diagnosis of mild steatorrheea may be avoided by the use of an inert internal indicator such as chromium sesque-oxide (Rose, 1964) . The jejunal mucosa is normal in cases of steatorrhoea due to mechanical disfunction or to defective digestion of fat. In the cceliac syndrome the mucosa is atrophic and flat and fat absorption is impaired. The cceliac syndrome may be "primary" (idiopathic steatorrhoea or ceeliac disaese) or "secondary" in that it is accompanied by one or other of a heterogeneous group of conditions (e.g. ulcerative colitis, diabetes, scleroderma with systemic sclerosis, reticulosis or a number of chronic skin conditions such as rosacea, eczema and psoriasis). It has been claimed that the incidence of improvement on a gluten-free diet is as high (80 %) in cases of secondary ceeliac syndrome as it is in idiopathic steatorrhcea (Hindle and Creamer, 1965 ).
The diagnostic significance, prior to biopsy, of the xylose excretion test (Fowler and Cooke, 1960) and the determination of FIGLU after histidine loading (Luhby and Cooperman, 1964) have been well documented in cases of idiopathic steatorrhoea but further evaluation of these tests in the secondary ceeliac syndrome is required.
Osteomalacia in phosphaturic rickets and in ureemic osteodystrophy is "resistant" to vitamin D. Hypocalcemia and severe secondary hyperparathyroidism are rare in the former but common in the latter condition. Many tests have been described which, although capable of providing quantitative data for research on various aspects of metabolic bone disease, lack the discriminatory power to form useful diagnostic tests in individual cases. The study of bone turnover with radio-isotopes and of the response to infusions of calcium or phosphate (Lancet, 1965) measurements of ionized calcium (Dale and Kellerman, 1967) and citrate (Hodgkinson, 1963) in blood and of hydroxyproline in urine (Dull and Henneman, 1963) 
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Knowledge of the abnormalities of plasma proteins in disease has been handicapped in part by limitation of knowledge of the physiology of proteins, of techniques of study of proteins and of nomenclature. Now that immunochemical means permit study of individual proteins specifically in the complex mixture of proteins that is plasma it is important that nomenclature should be geared to such individually definable substances. Similarly, it is important to recognise that, though there are a few exceptions, the majority of diseases of plasma proteins are quantitative rather than qualitative. Data can be interpreted sensibly only if it is known where the protein is made and how fast, where it is distributed and where it is destroyed and how fast. Detailed information of this type is quite remarkably limited, but two useful generalisations are that most proteins are made in the liver with the exception of the immunoglobulins which are made in the plasma cells, and though we speak of plasma proteins, most of them are present in the extra-ceIlular extravascular fluid in amounts comparable with that in the blood compartment. But passage through capillary membranes and through other biological membranes is related to molecular size-the small ones go through more readily than the big ones. These generalisations lead to the division of plasma protein abnormalities into three main groupsquantitative elevation, quantitative reduction and qualitative abnormality. The first two arise as a result of excessive or deficient production, excessive or deficient destruction, loss or disturbance of distribution. Qualitative abnormality arises as a result of production of a protein not normally produced, complete failure to produce a protein, or production of a protein, which is qualitatively abnormal and also from alteration due to involvement in a reaction.
Much of the physiological basis of these assertions derives from techniques entailing separation and purification of individual plasma proteins, with such metabolic studies as isotope labelling for study of distribution. catabolism etc. This has been possible for only a relatively small number of proteins and for a relatively small number of disease processes. Data of this type can also be obtained by immunochemical estimation of individual plasma proteins by such simple techniques as the gel diffusion precipitin procedure. Because of the great senstitivity and constant coefficient of variation of the methods they are particularly applicable to studies of deficienciesand to such physiological phenomena as the transmission through membranes. Evidence for the quantitative nature of the technique can be obtained by correlating the results of such estimations in plasma from a range of disease processes with the results of an independent method of measurement of the protein, where it is available. The precision of the fit broadly correlates with the validity of the non-immunochemical technique of measurement. Thus, though there is significant correlation between the immunochemical estimation of coeruloplasmin and the concentration of serum copper, there is a considerable scatter and a positive intercept, but immunochemical data correlate very precisely with the enzymatic estimation of coeruloplasmin by its capacity to oxidise paraphenylinediamine. Individual results significantly deviating from such correlations may provide a pointer to functionally defective proteins. Table I illustrates examples of the theoretical possible alterations of individual plasma protein concentrations classified according to whether the abnormality affects an individual protein specifically, affects a group of plasma proteins in parallel or affects all plasma proteins nonspecifically. Examples of these, most ofwhich are demonstrable by immunochemical study of the plasma proteins in the disease state, are given.
Where proteins are grossly deficient, repeated estimation of serum concentrations, following infusion of whole plasma, permits metabolic decay data of the protein to be obtained. This
